Management of Duane retraction syndrome with prismatic glasses
Received 8 October 2016
Accepted for publication 15 December 2016
Published 12 April 2017 Volume 2017:11 Pages 697—700
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Ebru Demet Aygit,1 Murat Kocamaz,1 Asli Inal,1 Korhan Fazil,1 Osman Bulut Ocak,1 Serpil Akar,2 Birsen Gokyigit1
1Strabismus Department, Beyoglu Eye Training and Research Hospital, Istanbul, Turkey; 2Ophthalmology Department, Medicine Faculty, Baskent University, Istanbul, Turkey
Purpose: To report the results of using prismatic glasses for Duane retraction syndrome (DRS).
Methods: Data were obtained from the records of patients who were evaluated during the year 2000 in the Strabismus Unit of the Beyoglu Eye Training and Research Hospital. The average follow-up was 12.2±17.7 months. In all cases, 2 main variables were evaluated: horizontal deviation in the primary position and face turn. Prismatic glasses were provided to patients according to the degree of shift in the primary position.
Results: The mean age of patients was 11.2 years. An analysis was performed on the data collected from 12 cases; 7 patients were females (58.3%) and 5 were males (41.7%), with 11 (91.7%) cases being of type I DRS. All 12 patients had abnormal head posture (face turn) and an angle of mean deviation equaling 10 PD (prism dioptri).
Conclusion: Treatment was individualized on a case-by-case basis. Prismatic glasses are useful for eliminating abnormal head posture and ocular misalignment in selected cases.
Keywords: Duane, prismatic glasses, abnormal head posture
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]